Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T17:22:49.905Z.
Calculation as of: 2026-10-06T17:22:49.905Z.
Quote observation: 2026-10-06T16:50:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 05f4ae4a030aaca39f2691a5695262832c6d48704f11c5316ed8238ac0b3761e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Niki BioSolutions, Inc.
Market Cap
$381125.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$484571.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243502.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$556226.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108688.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$665292.00
Operating Cash Flow Yield
18705.47%
TTM Avg
1695.05%
3Y Avg
1337.72%
5Y Avg
1337.72%
Market Cap
$95285.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$72318.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niki BioSolutions, Inc. (NIKI) | $381125.00 | N/A | N/A | N/A | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $484571.00 | N/A | N/A | N/A | N/A |
| SciSparc Ltd. (SPRC)vs › | $243502.00 | N/A | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $556226.00 | N/A | N/A | N/A | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108688.00 | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $665292.00 | 18705.47% | 1695.05% | 1337.72% | 1337.72% |
| Psyence Biomedical Ltd. (PBM)vs › | $95285.00 | N/A | N/A | N/A | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $72318.00 | N/A | N/A | N/A | N/A |
| Akanda Corp. (AKAN)vs › | $61819.00 | N/A | N/A | N/A | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30755.00 | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
